Project title: Chemical and cell biological technical development at Avidin Ltd.
Avidin successfully completed a project entitled Multiparametric immunophenotypic study to characterize diabetes patients, of Competitiveness and Excellence Co-operations (VKE)
Avidin succesfully completed project of EUREKA Innovation Award (E!12655 MITOME)
Avidin has detected new Delta variant in Hungary
Distribution ended for AKSCI products
Avidin has now developed a method for measuring B-cell immunity.
Q134R: Small chemical compound with NFAT inhibitory properties improves behavioral performance and synapse function in mouse models of amyloid pathology.
Avidin has developed a novel blood based diagnostic test that measures acquired T-cell immunity against the SARS-CoV2 coronavirus, following infection or immunization. Avidin is the first private company to offer such a test in Hungary.
Avidin’s Budapest site (Berlini u 47-49) was accredited as M3 authorization level of microbiological diagnostics laboratory.